| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Departments of Gastroenterology and Clinical Research (H.-P.B., B.G.), University of Berne, CH-3010 Berne, Switzerland; Department of Pharmacology (B.M.), Medical School, Philipps University, D-35033 Marburg, Germany; and Clinical Research Unit for Gastrointestinal Endocrinology (R.D.), Department of Medicine, Philipps University, D-35033 Marburg, Germany
Address all correspondence and requests for reprints to: Dr. H.-P. Bode, Departments of Clinical Research and Gastroenterology, University of Berne, Murtenstrasse 35, CH-3010 Berne, Switzerland. E-mail: bode{at}dkf4.unibe.ch
Glucagon-like peptide 1 (736)amide (GLP-1) is an insulinotropic intestinal peptide hormone with a potential role as antidiabetogenic therapeutic agent. It mediates a potentiation of glucose-induced insulin secretion, by activation of adenylate cyclase and subsequent elevation of cytosolic free calcium, [Ca2+]cyt. We investigated the role of protein kinase A (PKA) in GLP-1 signal transduction, using isolated mouse islets as well as the differentiated ß-cell line INS-1. Two specific inhibitors of PKA, (Rp)-adenosine cyclic 3',5'-phosporothioate (Rp-cAMPS, up to 3 mM) and KT5720 (up to 10 µM), did not inhibit the GLP-1-induced [Ca2+]cyt elevation. Another PKA inhibitor, H-89, reduced the [Ca2+]cyt elevation only when applied at high concentrations (1040 µM), higher than sufficient for PKA inhibition in many cell types. Furthermore, at these concentrations, H-89 also inhibited presumably PKA-independent processes such as glucose-induced [Ca2+]cyt elevations and intracellular calcium storage. This suggests a PKA-independent action of H-89. Similarly to H-89, the potent but unselective protein kinase inhibitor staurosporine inhibited the GLP-1-induced [Ca2+]cyt elevation only at high concentrations, at which it also inhibited glucose-induced [Ca2+]cyt elevations. The same observations as with GLP-1 were made when adenylate cyclase was stimulated with forskolin, for selective examination of signal transduction downstream of receptor and G protein. Our results suggest that the GLP-1-induced [Ca2+]cyt elevation is mediated independently of PKA and thus belongs to the yet-little-characterized ensemble of effects that are mediated by binding of cAMP to other target proteins.
This article has been cited by other articles:
![]() |
A. J. Murray Pharmacological PKA Inhibition: All May Not Be What It Seems Sci. Signal., June 3, 2008; 1(22): re4 - re4. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shibasaki, H. Takahashi, T. Miki, Y. Sunaga, K. Matsumura, M. Yamanaka, C. Zhang, A. Tamamoto, T. Satoh, J.-i. Miyazaki, et al. Essential role of Epac2/Rap1 signaling in regulation of insulin granule dynamics by cAMP PNAS, December 4, 2007; 104(49): 19333 - 19338. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Fridlyand, M. C. Harbeck, M. W. Roe, and L. H. Philipson Regulation of cAMP dynamics by Ca2+ and G protein-coupled receptors in the pancreatic -cell: a computational approach Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1924 - C1933. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Granata, F. Settanni, L. Biancone, L. Trovato, R. Nano, F. Bertuzzi, S. Destefanis, M. Annunziata, M. Martinetti, F. Catapano, et al. Acylated and Unacylated Ghrelin Promote Proliferation and Inhibit Apoptosis of Pancreatic {beta}-Cells and Human Islets: Involvement of 3',5'-Cyclic Adenosine Monophosphate/Protein Kinase A, Extracellular Signal-Regulated Kinase 1/2, and Phosphatidyl Inositol 3-Kinase/Akt Signaling Endocrinology, February 1, 2007; 148(2): 512 - 529. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dolz, D. Bailbe, M.-H. Giroix, S. Calderari, M.-N. Gangnerau, P. Serradas, K. Rickenbach, J.-C. Irminger, and B. Portha Restitution of Defective Glucose-Stimulated Insulin Secretion in Diabetic GK Rat by Acetylcholine Uncovers Paradoxical Stimulatory Effect of {beta}-Cell Muscarinic Receptor Activation on cAMP Production Diabetes, November 1, 2005; 54(11): 3229 - 3237. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dardevet, M. C. Moore, C. A. DiCostanzo, B. Farmer, D. W. Neal, W. Snead, M. Lautz, and A. D. Cherrington Insulin secretion-independent effects of GLP-1 on canine liver glucose metabolism do not involve portal vein GLP-1 receptors Am J Physiol Gastrointest Liver Physiol, November 1, 2005; 289(5): G806 - G814. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Seino and T. Shibasaki PKA-Dependent and PKA-Independent Pathways for cAMP-Regulated Exocytosis Physiol Rev, October 1, 2005; 85(4): 1303 - 1342. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kang, O. G Chepurny, M. J Rindler, L. Collis, Z. Chepurny, W.-h. Li, M. Harbeck, M. W Roe, and G. G Holz A cAMP and Ca2+ coincidence detector in support of Ca2+-induced Ca2+ release in mouse pancreatic {beta} cells J. Physiol., July 1, 2005; 566(1): 173 - 188. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. D'Alessio and T. P. Vahl Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E882 - E890. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Holz Epac: A New cAMP-Binding Protein in Support of Glucagon-Like Peptide-1 Receptor-Mediated Signal Transduction in the Pancreatic {beta}-Cell Diabetes, January 1, 2004; 53(1): 5 - 13. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Miura and H. Matsui Glucagon-like peptide-1 induces a cAMP-dependent increase of [Na+]i associated with insulin secretion in pancreatic {beta}-cells Am J Physiol Endocrinol Metab, November 1, 2003; 285(5): E1001 - E1009. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Arnette, T. B. Gibson, M. C. Lawrence, B. January, S. Khoo, K. McGlynn, C. A. Vanderbilt, and M. H. Cobb Regulation of ERK1 and ERK2 by Glucose and Peptide Hormones in Pancreatic {beta} Cells J. Biol. Chem., August 29, 2003; 278(35): 32517 - 32525. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Mayo, L. J. Miller, D. Bataille, S. Dalle, B. Goke, B. Thorens, and D. J. Drucker International Union of Pharmacology. XXXV. The Glucagon Receptor Family Pharmacol. Rev., March 1, 2003; 55(1): 167 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kang, J. W. Joseph, O. G. Chepurny, M. Monaco, M. B. Wheeler, J. L. Bos, F. Schwede, H.-G. Genieser, and G. G. Holz Epac-selective cAMP Analog 8-pCPT-2'-O-Me-cAMP as a Stimulus for Ca2+-induced Ca2+ Release and Exocytosis in Pancreatic beta -Cells J. Biol. Chem., February 28, 2003; 278(10): 8279 - 8285. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gomez, C. Pritchard, and T. P. Herbert cAMP-dependent Protein Kinase and Ca2+ Influx through L-type Voltage-gated Calcium Channels Mediate Raf-independent Activation of Extracellular Regulated Kinase in Response to Glucagon-like Peptide-1 in Pancreatic beta -Cells J. Biol. Chem., December 6, 2002; 277(50): 48146 - 48151. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nakazaki, A. Crane, M. Hu, V. Seghers, S. Ullrich, L. Aguilar-Bryan, and J. Bryan cAMP-Activated Protein Kinase-Independent Potentiation of Insulin Secretion by cAMP Is Impaired in SUR1 Null Islets Diabetes, December 1, 2002; 51(12): 3440 - 3449. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. MacDonald, W. El-kholy, M. J. Riedel, A. M. F. Salapatek, P. E. Light, and M. B. Wheeler The Multiple Actions of GLP-1 on the Process of Glucose-Stimulated Insulin Secretion Diabetes, December 1, 2002; 51(90003): S434 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kashima, T. Miki, T. Shibasaki, N. Ozaki, M. Miyazaki, H. Yano, and S. Seino Critical Role of cAMP-GEFII{middle dot}Rim2 Complex in Incretin-potentiated Insulin Secretion J. Biol. Chem., November 30, 2001; 276(49): 46046 - 46053. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, J. Zhou, M. E. Doyle, and J. M. Egan Glucagon-Like Peptide-1 Causes Pancreatic Duodenal Homeobox-1 Protein Translocation from the Cytoplasm to the Nucleus of Pancreatic {beta}-Cells by a Cyclic Adenosine Monophosphate/Protein Kinase A-Dependent Mechanism Endocrinology, May 1, 2001; 142(5): 1820 - 1827. [Abstract] [Full Text] |
||||
![]() |
D. J. Drucker Minireview: The Glucagon-Like Peptides Endocrinology, February 1, 2001; 142(2): 521 - 527. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |